We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LO
201
DELISTED
LORILLARD INC COM STK
LO
| $34M | 0.1% |
519,737
+2,880
| +0.6% | +$192K |
|
202
AvalonBay Communities
AVB
$26.8B
| $33.4M | 0.1% |
191,480
+17,466
| +10% | +$3.02M |
|
203
Ventas
VTR
$44.7B
| $33.4M | 0.1% |
400,112
+29,236
| +8% | +$2.52M |
|
204
Ameriprise Financial
AMP
$48.1B
| $32.5M | 0.09% |
248,407
-5,933
| -2% | -$782K |
|
205
PACCAR
PCAR
$70.4B
| $32.5M | 0.09% |
771,429
+3,825
| +0.5% | +$163K |
|
206
Carnival Corporation Ltd
CCL
$38B
| $31.9M | 0.09% |
667,047
-2,822
| -0.4% | -$127K |
|
207
O'Reilly Automotive
ORLY
$72.4B
| $31.8M | 0.09% |
2,206,710
-31,590
| -1% | -$425K |
|
208
AutoZone
AZO
$49.1B
| $31.6M | 0.09% |
46,362
-516
| -1% | -$324K |
|
209
Macy's
M
$6.56B
| $31.5M | 0.09% |
485,618
-3,530
| -0.7% | -$227K |
|
|
CERN
210
DELISTED
Cerner Corp
CERN
| $31.5M | 0.09% |
430,255
-2,850
| -0.7% | -$197K |
|
211
Lumen
LUMN
$6.76B
| $31M | 0.09% |
896,269
-32,090
| -3% | -$1.2M |
|
212
Boston Scientific
BSX
$68.4B
| $30.9M | 0.09% |
1,740,105
-24,639
| -1% | -$389K |
|
213
Freeport-McMoran
FCX
$91.2B
| $30.9M | 0.09% |
1,629,079
-38,502
| -2% | -$762K |
|
214
Bath & Body Works
BBWI
$4.02B
| $30.7M | 0.09% |
402,574
-705
| -0.2% | -$50.9K |
|
215
Dollar General
DG
$28.1B
| $30.6M | 0.09% |
405,312
+1,135
| +0.3% | +$80.3K |
|
216
Omnicom Group
OMC
$21.8B
| $30.3M | 0.09% |
387,931
-1,570
| -0.4% | -$120K |
|
217
Estee Lauder
EL
$30.7B
| $30.2M | 0.09% |
363,371
-22,479
| -6% | -$1.77M |
|
218
International Paper
IP
$22.8B
| $30.1M | 0.09% |
573,716
-7,846
| -1% | -$407K |
|
219
Healthpeak Properties
DOC
$15.2B
| $29.7M | 0.09% |
753,451
+74,412
| +11% | +$2.99M |
|
|
MJN
220
DELISTED
Mead Johnson Nutrition Company
MJN
| $29.5M | 0.09% |
293,838
+3,283
| +1% | +$331K |
|
221
Prologis
PLD
$136B
| $29.4M | 0.08% |
673,928
-4,485
| -0.7% | -$197K |
|
222
Boston Properties
BXP
$11.4B
| $29.1M | 0.08% |
206,820
-470
| -0.2% | -$65.6K |
|
|
BRCM
223
DELISTED
BROADCOM CORP CL-A
BRCM
| $28.9M | 0.08% |
667,681
-14,154
| -2% | -$617K |
|
|
HES
224
DELISTED
Hess
HES
| $28.7M | 0.08% |
423,143
-32,790
| -7% | -$2.34M |
|
|
FISV
225
Fiserv Inc
FISV
$28.8B
| $28.4M | 0.08% |
716,076
-13,440
| -2% | -$512K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.